Acumen Historical Income Statement
| ABOS Stock | USD 2.20 0.06 2.65% |
Historical analysis of Acumen Pharmaceuticals income statement accounts such as Interest Income of 8.6 M, Depreciation And Amortization of 174.8 K or Interest Expense of 552 K can show how well Acumen Pharmaceuticals performed in making a profits. Evaluating Acumen Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Acumen Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Acumen Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Acumen Pharmaceuticals is a good buy for the upcoming year.
Acumen |
About Acumen Income Statement Analysis
Acumen Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Acumen Pharmaceuticals shareholders. The income statement also shows Acumen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Acumen Pharmaceuticals Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Acumen Pharmaceuticals. It is also known as Acumen Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Acumen Pharmaceuticals income statement and represents the costs associated with goods and services Acumen Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Acumen Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Acumen Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.At this time, Acumen Pharmaceuticals' Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 8.6 M in 2024, whereas Interest Expense is likely to drop slightly above 552 K in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 84K | 2.4M | 8.2M | 8.6M | Net Interest Income | 84K | 2.4M | 8.2M | 8.6M |
Acumen Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Acumen Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.